Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Julianne Chen"'
Autor:
Partow Kebriaei, Julianne Chen, Demetrios Petropoulos, Muzaffar H. Qazilbash, Richard E. Champlin, Samer A. Srour, Jeremy Ramdial, Gabriela Rondon, Piyanuch Kongtim, Elizabeth J. Shpall, Uday R. Popat, Stefan O. Ciurea
Publikováno v:
American Journal of Hematology. 95:1187-1192
Relapse after allogeneic hematopoietic stem-cell transplantation (AHSCT) is associated with very poor outcomes. A second transplant offers the possibility of long-term disease control. We analyzed outcomes with haploidentical donors for second allogr
Autor:
Stefan O. Ciurea, Oran Betul, Julianne Chen, Maria C.B. Bittencourt, Richard E. Champlin, Samer A. Srour, Jeremy Ramdial, Gabriela Rondon, Partow Kebriaei, Uday R. Popat, Elizabeth J. Shpall, Qaiser Bashir, Piyanuch Kongtim, Amanda Olson, Issa F. Khouri
Publikováno v:
American Journal of Hematology. 95
Autor:
Roy F. Chemaly, Lindsey Lombardi, Gabriela Rondon, Richard E. Champlin, Alison M. Gulbis, Julianne Chen, Sai Ravi Pingali, Denái R. Milton, Aimee E. Hammerstrom, Stefan O. Ciurea
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:353-358
Cytomegalovirus (CMV) infection can increase the morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Because of a higher degree of immunosuppression, haploidentical transplant recipients may be at an increased risk of v
Autor:
Partow Kebriaei, Jonathan E. Brammer, Sameh Gaballa, Rima M. Saliba, Michael Andreeff, Farhad Ravandi, Uday R. Popat, Jorge E. Cortes, Julianne Chen, Naval Daver, Stefan O. Ciurea, Gabriela Rondon, Amin M. Alousi, Keyur P. Patel, Elias Jabbour, David Marin, Richard E. Champlin, Betul Oran, Elizabeth J. Shpall, Borje S. Andersson
Publikováno v:
American Journal of Hematology. 92:331-337
In patients with AML with FMS-like tyrosine kinase 3 (FLT3) mutations, the significance of minimal residual disease (MRD) detected by PCR before allogeneic stem cell transplantation (SCT) on outcomes after transplant remains unclear. We identified 20
Autor:
Aimee E. Hammerstrom, Stefan O. Ciurea, Uday R. Popat, Muzaffar H. Qazilbash, Gabriela Rondon, Rima M. Saliba, Sairah Ahmed, Julianne Chen, Chitra Hosing, Richard E. Champlin, Amin M. Alousi, Qaiser Bashir, Issa F. Khouri, Elizabeth J. Shpall, Rohtesh S. Mehta
Publikováno v:
British Journal of Haematology. 173:444-455
Post-transplantation cyclophosphamide (PTCy) is an effective strategy to prevent graft-versus-host disease (GVHD) after haploidentical haematopoietic cell transplantation (HCT). We determined the efficacy of PTCy-based GVHD prophylaxis in human leuco
Autor:
Julianne Chen, Gheath Alatrash, Richard E. Champlin, Stefan O. Ciurea, Katayoun Rezvani, Gabriela Rondon, Denái R. Milton, Ulas D. Bayraktar, Michele Guindani
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:505-513
PURPOSE: The recovery pace of absolute lymphocyte count (ALC) is prognostic after hematopoietic stem cell transplantation (SCT). Previous studies have evaluated a wide range of ALC cutoffs and time points to predict outcomes. We aimed to determine th
Autor:
Issa F. Khouri, Elizabeth J. Shpall, Roland L. Bassett, Uday R. Popat, Elias Jabbour, Xinyan Lu, Stefan O. Ciurea, Julianne Chen, Jorge E. Cortes, Farhad Ravandi, Richard E. Champlin, Gautam Borthakur, Antonio M. Jimenez, Muzaffar H. Qazilbash, Betul Oran, Marcos de Lima, Qaiser Bashir, Borje S. Andersson, Partow Kebriaei, Gabriela Rondon
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(8):1405-1412
We evaluated the prognostic significance of a modified European LeukemiaNet (ELN) classification for patients with acute myelogenous leukemia (AML) undergoing hematopoietic stem cell transplantation (HSCT) while in first complete remission (CR1). We
Autor:
Stefan O. Ciurea, Elizabeth J. Shpall, Julianne Chen, Celina Ledesma, Issa F. Khouri, Gabriela Rondon, Chitra Hosing, Partow Kebriaei, Betul Oran, Uday R. Popat, Richard E. Champlin, Amin M. Alousi, Rima M. Saliba
Fluid overload (FO) commonly occurs during hospitalization for allogeneic hematopoietic stem cell transplantation. We hypothesized that FO is associated with transplantation outcomes and evaluated this complication in 2 cohorts of patients. FO was gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160fc8449d32d80366081fcf720b2c35
https://europepmc.org/articles/PMC5889108/
https://europepmc.org/articles/PMC5889108/
Autor:
Katayoun Rezvani, Richard E. Champlin, Piyanuch Kongtim, Betul Oran, Issa F. Khouri, Julianne Chen, Dean A. Lee, David Marin, Demetrios Petropoulos, Amin M. Alousi, Gheath Alatrash, Riad El Fakih, Gabriela Rondon, Partow Kebriaei, Sa A. Wang, Martin Korbling, Ciprian Tomuleasa, Chitra Hosing, Aimee E. Hammerstrom, Muzaffar H. Qazilbash, Isabell Ge, Yago Nieto, Stefan O. Ciurea, Sameh Gaballa, Kai Cao, Qaiser Bashir, Elizabeth J. Shpall, Uday R. Popat, Jonathan E. Brammer, Lindsey Lombardi, Sairah Ahmed, Nina Shah
Publikováno v:
Cancer, vol 122, iss 21
BACKGROUND High-dose, post-transplantation cyclophosphamide (PTCy) to prevent graft-versus-host disease (GVHD) has improved outcomes in haploidentical (HAPLO) stem cell transplantation (SCT). However, it remains unclear whether this strategy is effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9db514c7d6fbf9968183bdf3943d1ae
https://escholarship.org/uc/item/4vw4v89t
https://escholarship.org/uc/item/4vw4v89t
Autor:
Marcos de Lima, Sergio Giralt, Heather Lin, Hagop M. Kantarjian, Jorge E. Cortes, Naveen Pemmaraju, Muzaffar H. Qazilbash, Maria Florencia Tanaka, Veerabhadran Baladandayuthapani, Julianne Chen, Gabriela Rondon, Farhad Ravandi, Richard E. Champlin, Sherry Pierce
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 13:485-492
Background Outcomes in patients with acute promyelocytic leukemia (APL) have improved; however, a significant number of patients still relapse despite receiving all- trans -retinoic acid (ATRA) and arsenic-based therapies. Patients and Methods Outcom